China Meheco Group(600056.SH): Clarithromycin Tablet Passes Generic Drug Consistency Evaluation.
China Medical (600056.SH) announced that its wholly-owned subsidiary, Tianfang Pharmaceutical Co., Ltd. (hereinafter referred to as "Tianfang Pharmaceutical"), recently received the approval notice for the supplementary application for the approval of clarithromycin tablets (hereinafter referred to as "the drug") issued by the National Medical Products Administration (hereinafter referred to as "NMPA"). The drug has passed the generic drug quality and efficacy consistency evaluation.
China Meheco Group (600056.SH) issued an announcement that its wholly-owned subsidiary, Tianfang Pharmaceutical Co., Ltd. (hereinafter referred to as "Tianfang Pharmaceutical"), recently received the approval notice for the supplementary drug application of clarithromycin tablets (hereinafter referred to as "the drug") issued by the National Medical Products Administration. The drug has passed the evaluation of generic drug quality and efficacy consistency.
Related Articles
Shanghai XNG (03666): He Qinghua Appointed as Executive Director
MTT GROUP (02350) intends to acquire 100% equity of Hong Kong Wise Wave Technology for HK$87.5 million. Trading will resume on January 2, 2026.
NOAH HOLDINGS (06686) issued 2.7069 million shares of restricted stock units based on the previously announced settlement plan.
Shanghai XNG (03666): He Qinghua Appointed as Executive Director
MTT GROUP (02350) intends to acquire 100% equity of Hong Kong Wise Wave Technology for HK$87.5 million. Trading will resume on January 2, 2026.
NOAH HOLDINGS (06686) issued 2.7069 million shares of restricted stock units based on the previously announced settlement plan.
